Cargando…
Angiopoietin-Like 3 (ANGPTL3) and Atherosclerosis: Lipid and Non-Lipid Related Effects
Genetic and clinical studies have demonstrated that loss-of-function variants in the angiopoietin-like 3 (ANGPTL3) gene are associated with decreased plasma levels of triglycerides (TGs), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C), which leads to a...
Autores principales: | Lupo, Maria Giovanna, Ferri, Nicola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162638/ https://www.ncbi.nlm.nih.gov/pubmed/30011918 http://dx.doi.org/10.3390/jcdd5030039 |
Ejemplares similares
-
Role and mechanism of the action of angiopoietin-like protein ANGPTL4 in plasma lipid metabolism
por: Kersten, Sander
Publicado: (2021) -
Angiopoietin-Like Protein 3 (ANGPTL3) Inhibitors in the Management of Refractory Hypercholesterolemia
por: Kosmas, Constantine E, et al.
Publicado: (2022) -
Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia
por: Chen, Pei-Yi, et al.
Publicado: (2021) -
Impact of oral lipid and glucose tolerance tests on the postprandial concentrations of angiopoietin-like proteins (Angptl) 3 and 4
por: Schmid, Andreas, et al.
Publicado: (2021) -
Angiopoietin-like protein 3 (ANGPTL3) deficiency and familial combined hypolipidemia
por: Tarugi, Patrizia, et al.
Publicado: (2019)